关于 "Cancer stem cell" 的结果41+ 个结果

筛选:Apoptosis×
  • GC14882 structure
    Salinomycin
    CAS: 53003-10-4

    A selective cancer stem cell inhibitor

  • GC91154 structure
    33-BCRP Inhibitor

    一种BCRP抑制剂

    Apoptosis
  • GC14731 structure
    MTT
    CAS: 298-93-1

    A cell-permeable and positively charged tetrazolium dye

    Apoptosis
  • GC10171 structure
    Puromycin aminonucleoside
    CAS: 58-60-6

    A glomerular epithelial cell toxin

  • GC41261 structure
    Flavokawain B
    CAS: 1775-97-9

    Induces cancer cell apoptosis

  • GC50282 structure
    EC 19
    CAS: 1010694-08-2

    Synthetic retinoid; induces differentiation of stem cells

  • GC12861 structure
    Z-VAD-FMK
    CAS: 187389-52-2

    Z-VAD-FMK(苄氧羰基-Val-Ala-Asp(OMe)氟甲基酮),是一种类似ICE的蛋白酶抑制剂,通过阻止CPP32转化为其活性形式来抑制细胞凋亡。

  • GC60278 structure
    OT-82
    CAS: 1800487-55-1

    OT-82 is a novel nicotinamide phosphoribosyltransferase (NAMPT) inhibitor with average IC50s of 13.03 ??nM in non-HP cancer cells and 2.89? ?nM in HP cancer cells, respectively.

  • GC12961 structure
    Apicidin
    CAS: 183506-66-3

    A cell-permeable HDAC inhibitor

  • GC38606 structure
    Glaucocalyxin A
    CAS: 79498-31-0

    Glaucocalyxin A is a biologically active ent-kauranoid diterpenoid isolated from Rabdosia japonica var. glaucocalyx with antitumor and anti-inflammatory activity. Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells.

  • GC62676 structure
    TJ191
    CAS: 1522415-97-9

    TJ191 is a selective anti-cancer small molecule that targets low TβRIII-expressing malignant T-cell leukemia/lymphoma cells.

    Apoptosis
  • GC39155 structure
    PI-273
    CAS: 925069-34-7

    PI-273, the first reversibly and specific phosphatidylinositol 4-kinase (PI4KIIα) inhibitor with an IC50 of 0.47 μM, can inhibit breast cancer cell proliferation, block the cell cycle and induce cell apoptosis.

  • GC11908 structure
    Cisplatin
    CAS: 15663-27-1

    顺铂是最好的、最早的基于金属的化疗药物之一,用于治疗广泛的实体癌症,如睾丸癌、卵巢癌、膀胱癌、肺癌、宫颈癌、头颈部肿瘤和胃癌等。

  • GC61349 structure
    Tributyrin
    CAS: 60-01-5

    Glycerol tributyrate (Tributyrin) is a triglyceride that may inhibit cell growth and induce cell differentiation.

    Apoptosis
  • GC38609 structure
    Rotundic acid
    CAS: 20137-37-5

    Rotundic acid (Rutundic acid), a natural compound, exhibit cytotoxic activities toward human hepatocellular carcinoma (HepG2), malignant melanoma (A375), SCLC (NCI-H446), breast cancer (MCF-7), and colon cancer (HT-29) cell lines.RA induces cell cycle arrest, DNA damage, and apoptosis by modulating the AKT/mTOR and MAPK pathways.

  • GC43105 structure
    C8 Ceramide (d18:1.8:0)
    CAS: 74713-59-0

    A cell-permeable ceramide analog

  • GC60317 structure
    RA-9
    CAS: 919091-63-7

    RA-9 is a cell-permeable, potent and selective inhibitor of proteasome-associated deubiquitinating enzymes (DUBs) with favorable toxicity profile and anticancer activity. RA-9 selectively induces apoptosis in ovarian cancer cell lines.

  • GC60288 structure
    Picrocrocin
    CAS: 138-55-6

    Picrocrocin, the chemical most responsible for the bitter taste of saffron, is isolated from saffron and inhibits proliferation of cancer cells.

    Apoptosis
  • GC62443 structure
    ErSO
    CAS: 2407860-35-7

    ErSO activates the anticipatory unfolded protein response (a-UPR) with an IC50 of 20.3 nM in MCF-7 cells. ErSO induces rapid and selective necrosis of ERα-positive breast cancer cell lines in vitro.

    Apoptosis
  • GC65290 structure
    Sintilimab
    CAS: 2072873-06-2

    Sintilimab (anti-PD-1, IBI 308) is a fully human IgG4 monoclonal antibody that binds to PD-1 on the surface of T-cells, blocks the PD-1/PD-Ligand 1 (PD-L1) pathway, and reactivates T-cells to kill cancer cells.

  • GC34218 structure
    Nivolumab (BMS-936558)
    CAS: 946414-94-4

    Nivolumab 是一种抗癌单克隆抗体,是一种程序性死亡受体-1 阻断人 IgG4 抗体,用于治疗晚期(转移性)非小细胞肺癌。

  • GC16362 structure
    AD57 (hydrochloride)
    CAS: 2320261-72-9

    A polypharmacological cancer therapeutic

  • GC14847 structure
    Psoralidin
    CAS: 18642-23-4

    A furanocoumarin with anti-cancer activity

  • GC38086 structure
    Linderalactone
    CAS: 728-61-0

    Linderalactone inhibits human lung cancer growth by modulating the expression of apoptosis-related proteins (Bax and Bcl-2) with an IC50 of 15 ?M in A-549 cells. Linderalactone induces G2/M cell cycle arrest and could also suppress the JAK/STAT signalling pathway. Linderalactone can be isolated from Radix linderae.